Sio Gene Therapies Inc.
SIOXDelisted Apr 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636050
Sio Gene Therapies Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Feb 10, 2022; 37 institutions reported holding it in 13F filings for Q4 2022, worth $8.09M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 37
- Q4 2022, 0 vs. previous quarter
- 13F value
- $8.09M
- Reported value at the end of Q4 2022
- Superinvestors holding
- 0
- At the end of Q4 2022
Superinvestors holding SIOX, Q4 2022
No superinvestor reported holding SIOX at the end of Q4 2022.
Latest insider trades
Open-market purchases and sales by Sio Gene Therapies Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Sio Gene Therapies Inc. insiders are on file.
Top 10 13F holders, Q4 2022
The largest institutional positions in Sio Gene Therapies Inc. at the end of Q4 2022; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 7,000,000 | $3.04M | 0.13% | 00.0% | Unchanged |
| Newtyn Management, LLC | 3,000,000 | $1.30M | 0.27% | +1,500,000+100.0% | Added |
| Tang Capital Management LLC | 2,000,000 | $870.0K | 0.13% | +2,000,000 | New |
| Vanguard Group Inc | 1,739,923 | $756.9K | 0.00% | −100,784−5.5% | Reduced |
| Morgan Stanley | 1,512,380 | $657.9K | 0.00% | +1,500,000+12,116.3% | Added |
| Geode Capital Management, LLC | 432,270 | $188.0K | 0.00% | −1,116−0.3% | Reduced |
| JBF Capital, Inc. | 429,600 | $186.9K | 0.05% | +429,600 | New |
| Renaissance Technologies LLC | 409,284 | $178.0K | 0.00% | +47,284+13.1% | Added |
| BlackRock Inc. | 390,386 | $169.8K | 0.00% | −70.0% | Reduced |
| Western Standard LLC | 294,397 | $128.1K | 0.11% | +294,397 | New |